Surgery Partners revises 2025 outlook to $3.275B-$3.3B revenue amid capital deployment delays and volume softness (NASDAQ:SGRY)

技术访问问题 - 浏览器需启用Javascript和cookies以确保未来正常访问 [1] - 启用广告拦截器可能导致访问被阻止 需禁用并刷新页面 [1]